The largest database of trusted experimental protocols

Amaxa nucleofector unit

Manufactured by Lonza

The Amaxa nucleofector unit is a laboratory instrument designed for the transfection of cells. It delivers an electrical pulse to temporarily permeabilize the cell membrane, allowing the introduction of nucleic acids or other molecules into the cell's interior.

Automatically generated - may contain errors

4 protocols using amaxa nucleofector unit

1

Differentiation of Cortical Neurons from Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stem cell cultures and neuronal differentiation were conducted as previously described 17 (link), 19 , 26 (link). Unless otherwise indicated human embryonic stem cell (hESCs) line H1 27 (link) was used to differentiate human cortical neurons for most of the experiments. In addition, human induced pluripotent stem cell (iPSC) line 20B 28 (link) was also used to differentiate human cortical neurons for studies that analyzed gene expression for CREB pathway components. For extensive methods used see supplementary methods section. shRNA lentiviral constructs targeting ASH1L, containing a puromycin resistance cassette were purchased from Sigma (Supplementary Table S10). For each reaction, 400,000 human cortical neurons 17 (link) between days 28 to 30 were nucleofected with control or ASH1L shRNAs constructs using the X-unit of the Amaxa nucleofector unit (Lonza, catalog # AAF1002X) per manufacturers protocol. Neurons were subjected to puromycin selection a day after nucleofection and were harvested 72 hours (hrs.) post puromycin treatment unless otherwise indicated. A detailed protocol is included in the supplementary methods.
+ Open protocol
+ Expand
2

Generation of Inducible SETD2 KO Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
To generate SETD2 KO cell lines (HBL1, OCI-Ly7, SU-DHL-4, SU-DHL-2), parental cells were transduced with lentivirus expressing doxycycline inducible Cas9 and blasticidin resistance gene (Addgene, #83481) followed by 5 days of blasticidin selection. Cas9 expressing cells were transduced with lentivirus expressing a SETD2 specific sgRNA (SETD2G#1: 5’ AAA GAA ACA ATA GTA GAA GT 3’; SETD2G#2: 5’ AAT CTG ATG AAG ATT CTG TA 3’) and GFP (Addgene, #57822). 4 days post doxycycline induction, GFP+ cells were single cell sorted into 96 well plates and allowed to grow for at least two weeks. For RIVA, parental cells were electroporated with Amaxa Nucleofector Unit and the SF Cell line 4D-Nucleofector X kit (Lonza, PBC2–22500) to incorporate a recombinant Cas9 nuclease (Alt-R S.p. Cas9 Nuclease V3, Integrated DNA Technologies, 1081058), a SETD2 targeting Alt-R CRISPR-Cas9 crRNA (SETD2G#1: 5’ AAA GAA ACA ATA GTA GAA GT 3’; SETD2G#2: 5’ AAT CTG ATG AAG ATT CTG TA 3’ Integrated DNA Technologies) and Alt-R CRISPR-Cas9 tracrRNA (Integrated DNA Technologies, 1075927) using manufacturer’s protocol. Forty-eight hours after electroporation, ATTO550+ single cells were sorted into 96 well plates and allowed to grow for at least two weeks. Clones were screened by PCR amplification of a 500bp region encompassing the CRISPR-Cas9 cleavage site and verified by sanger sequencing at GENEWIZ.
+ Open protocol
+ Expand
3

Differentiation of Cortical Neurons from Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stem cell cultures and neuronal differentiation were conducted as previously described 17 (link), 19 , 26 (link). Unless otherwise indicated human embryonic stem cell (hESCs) line H1 27 (link) was used to differentiate human cortical neurons for most of the experiments. In addition, human induced pluripotent stem cell (iPSC) line 20B 28 (link) was also used to differentiate human cortical neurons for studies that analyzed gene expression for CREB pathway components. For extensive methods used see supplementary methods section. shRNA lentiviral constructs targeting ASH1L, containing a puromycin resistance cassette were purchased from Sigma (Supplementary Table S10). For each reaction, 400,000 human cortical neurons 17 (link) between days 28 to 30 were nucleofected with control or ASH1L shRNAs constructs using the X-unit of the Amaxa nucleofector unit (Lonza, catalog # AAF1002X) per manufacturers protocol. Neurons were subjected to puromycin selection a day after nucleofection and were harvested 72 hours (hrs.) post puromycin treatment unless otherwise indicated. A detailed protocol is included in the supplementary methods.
+ Open protocol
+ Expand
4

DUOXA1 Knockdown and Overexpression Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Short hairpin RNA (shRNA) constructs targeting two separate regions of the DUOXA1 gene and a control construct targeting luciferase (3 μg) were used in knockdown experiments. All DUOXA1 shRNA constructs and controls were purchased from OriGene (Rockville, MD). At the appropriate cell density, myoblasts (6 × 105 cells/cuvette) were electroporated using an Amaxa Nucleofector unit and NHDF solution (Lonza, Walkerville, MD). Twenty-four hours after nucleofection, GM was replaced with DM, and cells were harvested after 48 hours of differentiation. Samples were harvested for mRNA, analyzed by microscopy or prepared for H2O2 determination. In order to determine whether knocking down DUOX1 or ASK1 might rescue the phenotype corresponding to DUOXA1 overexpression, siRNA constructs targeting DUOX1, ASK1 or a scrambled control were purchased from Santa Cruz (Santa Cruz, CA). Small interfering RNA was introduced into proliferative primary myoblasts using nucleofection described above. Twenty four hours after nucleofection, samples were infected with adenoviral vectors containing GFP-DUOXA1 or GFP alone. Differentiation was initiated 24 hours after infection and samples were harvested 24 or 48 hours later. Sequences used in the preparation of siRNA and shRNA are presented in Additional file
2: Table S1.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!